Published in J Allergy Clin Immunol on March 01, 1996
A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol (2003) 0.82
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations. Front Pharmacol (2016) 0.82
Combined effects of food and exercise on anaphylaxis. Nutr Res Pract (2013) 0.79
Human heart as a shock organ in anaphylaxis. Allergo J Int (2014) 0.77
Roles of intracellular Ca2+ and cyclic AMP in mast cell histamine release induced by radiographic contrast media. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.76
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J (1993) 1.84
Do we need to use sugammadex at the end of a general anesthesia to reverse the action of neuromuscular bloking agents? Position Paper on Sugammadex use. Minerva Anestesiol (2012) 1.46
In vitro effects of ultraviolet A on histamine release from human basophils. J Eur Acad Dermatol Venereol (2003) 1.40
No correlation between remifentanil blood, cerebrospinal fluid and cerebral extracellular fluid levels and TCI prediction: a pharmacokinetic study. Minerva Anestesiol (2014) 1.38
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol (1999) 1.33
Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation (1998) 1.33
Allergy and the cardiovascular system. Clin Exp Immunol (2008) 1.27
Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis (1988) 1.21
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J Immunol (1980) 1.19
Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) (2002) 1.19
Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy (2010) 1.17
Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol (1995) 1.17
Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol (1979) 1.17
Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. Eur J Ultrasound (1999) 1.14
HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol (2000) 1.11
Adenosine receptor on human basophils: modulation of histamine release. J Immunol (1979) 1.11
Characterization of a specific adenosine receptor on human lymphocytes. J Immunol (1978) 1.10
Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation (1986) 1.09
A meta-analysis of open versus arthroscopic Bankart repair using suture anchors. Knee Surg Sports Traumatol Arthrosc (2010) 1.08
Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth (2008) 1.08
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J Immunol (2000) 1.08
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med (1995) 1.06
Hemobilia, intrahepatic hematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoablation of a liver metastasis. Eur Radiol (2000) 1.04
The role of basophils and mast cells in the pathogenesis of pulmonary diseases. Int Arch Allergy Appl Immunol (1985) 1.03
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest (1994) 1.03
The mechanism of basophil histamine release induced by pepstatin A. J Immunol (1984) 1.02
Immunological characterization and functional importance of human heart mast cells. Immunopharmacology (1995) 1.01
Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol (2001) 1.01
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol (1998) 1.00
Expression of the chemokine receptor CCR3 on human mast cells. Int Arch Allergy Immunol (2001) 1.00
Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology (2001) 0.98
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol (1990) 0.97
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol (2001) 0.97
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J Immunol (1994) 0.96
Mast cells have a protumorigenic role in human thyroid cancer. Oncogene (2010) 0.96
Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics. J Int Med Res (1989) 0.95
Evidence for an adenosine A2/Ra receptor on human basophils. Life Sci (1985) 0.95
Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. J Pharmacol Exp Ther (1987) 0.95
Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc. J Pharmacol Exp Ther (1981) 0.94
IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. Int Arch Allergy Appl Immunol (1981) 0.94
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol (1987) 0.93
FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells. J Immunol (1991) 0.93
Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun (2000) 0.93
Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol (1983) 0.92
Bronchial thermoplasty in severe asthma: food for thoughts. Minerva Med (2014) 0.92
Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology (1988) 0.92
Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol (1992) 0.91
Possible role of calmodulin in human inflammatory reactions. Monogr Allergy (1983) 0.90
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology (1992) 0.90
Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol (1991) 0.90
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum (1996) 0.89
The clinical relevance of basophil releasability. J Allergy Clin Immunol (1994) 0.89
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol (1996) 0.89
Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. Clin Immunol Immunopathol (1981) 0.89
Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces. Calcif Tissue Int (1998) 0.89
Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. J Am Coll Cardiol (1987) 0.89
Eosinophil granule proteins activate human heart mast cells. J Immunol (1996) 0.89
Integrin expression on chondrocytes: correlations with the degree of cartilage damage in human osteoarthritis. Clin Exp Rheumatol (1997) 0.88
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. Clin Exp Immunol (1982) 0.88
Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents. J Pharmacol Exp Ther (1980) 0.88
Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol (2000) 0.88
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. Int Arch Allergy Appl Immunol (1984) 0.88
Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. J Immunol (1990) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. Int Arch Allergy Appl Immunol (1989) 0.88
Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. J Immunol (1995) 0.87
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. Int Arch Allergy Immunol (1995) 0.87
Adenosine receptors on human inflammatory cells. Int Arch Allergy Appl Immunol (1985) 0.87
The role of basophils in inflammatory reactions. J Invest Dermatol (1978) 0.87
In situ characterization of mast cells in the frog Rana esculenta. Cell Tissue Res (1998) 0.87
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy (2000) 0.86
Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol (1992) 0.86
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity. Clin Exp Allergy (1999) 0.86
Angiogenesis, lymphangiogenesis and atopic dermatitis. Chem Immunol Allergy (2012) 0.86
Molecular and cellular biology of mast cells and basophils. Int Arch Allergy Immunol (1997) 0.86
Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol (1995) 0.85
Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes. J Clin Lab Immunol (1983) 0.85
Chondrocyte phenotyping in human osteoarthritis. Clin Rheumatol (1998) 0.85
Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. Int J Clin Lab Res (1997) 0.85
Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol (1999) 0.85
The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes. Br J Haematol (1986) 0.85
Oxidative stress markers are increased in patients with mastocytosis. Allergy (2015) 0.85
Practical allergy (PRACTALL) report: risk assessment in anaphylaxis. Allergy (2008) 0.85
Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis (1990) 0.84